In Part II of an exclusive interview with GEN Edge, O’Neill and Mullen discuss Editas’ search for a new chief medical officer to succeed Lisa Michaels, MD, who was immediately terminated February 7 without explanation; which programs Editas will seek to partner; Editas’ response to an analyst who questioned how the company will assess the success of EDIT-101; and the company’s workforce expansion plans . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post Editas’ Current and Future CEOs Discuss CMO Search, EDIT-101, and Growth appeared first on GEN – Genetic Engineering and Biotechnology News.
